文献速递腹部技术与安全US

基于超声剪切波速度测量与血清学算法无创评估乙型病毒性肝炎患者肝纤维化分期的回顾性队列研究

Noninvasive Assessment of Liver Fibrosis Stage Using Ultrasound-Based Shear Wave Velocity Measurements and Serum Algorithms in Patients With Viral Hepatitis B: A Retrospective Cohort Study.
PubMed 文献 · J Ultrasound Med · 2016-12-31

该回顾性队列纳入174例慢性乙型肝炎患者,以肝穿刺活检为参考标准,比较剪切波速度(SWV)、APRI、FIB-4及AAR及其组合诊断肝纤维化分期的效能。SWV与APRI诊断显著纤维化(≥F2)优于FIB-4,AAR不适用;SWV诊断肝硬化(F4)最佳,SWV联合APRI可提高诊断效能。

要点

  • SWV诊断显著纤维化(≥F2)AUC 0.82、诊断肝硬化(F4)AUC 0.96,均优于APRI与FIB-4。
  • AAR诊断显著纤维化AUC 0.47、诊断肝硬化AUC 0.45,不适用于评估纤维化。
  • SWV联合APRI诊断显著纤维化AUC提高至0.85,诊断肝硬化敏感度提高至100%。

核心结论

  • SWV、APRI和FIB-4是评估显著肝纤维化和肝硬化的有效指标,多种无创指标联合有望提高肝纤维化分期的评估效能。

研究设计与样本

  • 回顾性队列研究,纳入174例慢性乙型肝炎患者,收集剪切波速度(SWV)与实验室指标,以经皮肝穿刺活检为参考标准,采用受试者工作特征曲线分析比较各无创指标的诊断效能。

诊断标准与关键数值

  • 显著纤维化(分期≥F2):SWV的AUC为0.82,APRI的AUC为0.77,FIB-4的AUC为0.62,AAR的AUC为0.47。
  • 肝硬化(F4):SWV的AUC为0.96,APRI的AUC为0.75,FIB-4的AUC为0.74,AAR的AUC为0.45。
  • SWV联合APRI:显著纤维化AUC提高至0.85,肝硬化敏感度提高至100%。

局限性

  • 原文指出确定最佳无创检测的研究是有必要的(studies to determine the optimal noninvasive test are warranted)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Liver biopsy remains the reference standard for the assessment of liver fibrosis, but this procedure is invasive and can lead to complications. Thus, studies to determine the optimal noninvasive test are warranted. This study compared several noninvasive tests and their combinations for evaluating liver fibrosis stages in patients with chronic hepatitis B.

METHODS: The shear wave velocity (SWV) and laboratory indicators were collected from 174 patients with chronic hepatitis B. Formulas were applied to calculate the serum fibrosis model, including the aspartate aminotransaminase-to-platelet ratio index (APRI), fibrosis-4 index (FIB-4) and aspartate aminotransferase-to-alanine aminotransferase ratio (AAR). The diagnostic performance of all noninvasive tests was assessed in comparison with percutaneous liver biopsy, based on a receiver operating characteristic curve analysis.

RESULTS: The SWV (area under the receiver operating characteristic curve [AUC], 0.82) and APRI (AUC = 0.77) performed better than the FIB-4 (AUC = 0.62), and the AAR (AUC = 0.47) was not suitable for evaluating substantial liver fibrosis (stage ≥F2). The SWV (AUC = 0.96) was the best indicator, being superior to the APRI (AUC = 0.75) and FIB-4 (AUC = 0.74), and the AAR (AUC = 0.45) was not suitable for assessing cirrhosis (F4). Combining the SWV and APRI, the AUC improved to 0.85 for substantial liver fibrosis, and the sensitivity increased to 100% for cirrhosis.

CONCLUSIONS: The SWV, APRI, and FIB-4 were valid tests for evaluating substantial liver fibrosis and cirrhosis. The combination of these tests with several noninvasive indicators is expected to enhance the assessment of liver fibrosis stages.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Liu J, Zhao J, Zhang Y, et al. Noninvasive Assessment of Liver Fibrosis Stage Using Ultrasound-Based Shear Wave Velocity Measurements and Serum Algorithms in Patients With Viral Hepatitis B: A Retrospective Cohort Study. J Ultrasound Med. 2016. PMID: 28039877. doi:10.7863/ultra.16.01069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。